Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GenturaDx Awarded Fifth Patent on Innovative Sample Prep Design

Published: Monday, March 26, 2012
Last Updated: Monday, March 26, 2012
Bookmark and Share
GenturaDx has been awarded its fifth patent from the U.S. patent office, which covers aspects of the sample cassette utilized by the IDbox™.

GenturaDx, has announced that is has been awarded its fifth patent from the U.S. patent office (U.S. Patent No. 8,124,024), which covers aspects of the sample cassette utilized by the IDbox™. The GenturaDx cassette design is part of the company's proprietary fully automated method of integrating extraction and purification of nucleic acids along with amplification and detection capabilities within the IDbox. This patent is specifically related to innovations within the integrated cassette that reduce the risk of Polymerase Chain Reaction (PCR) contamination that can cause false positive or erroneous results. By automating this important process, human error is minimized.

"The award of this patent supports our continued vision of bringing the highest quality of molecular diagnostic products to clinicians and patients. By simplifying these complex processes, we enable more health care providers with the most sensitive and accurate molecular tests," said GenturaDx Chief Scientific Officer Jesus Ching, Ph.D.

The fully integrated and automated design of the IDbox system will bring an easy-to-use, cost-effective and highly sensitive molecular testing capability to hospital laboratories. These laboratories will benefit from the decreased labor and enhanced workflow, while clinicians will benefit from receiving the most accurate result with rapid turnaround that ultimately allows for faster treatment and management of the patient. The company is currently performing clinical beta studies and heading towards clinical trials in third quarter 2012.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GenturaDx Announces Addition to Board of Directors
The newly appointed member, Michael Treble, is currently chairman and CEO of Axela, Inc. The five current directors will remain on the board.
Thursday, January 12, 2012
Scientific News
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
'Molecular Movie' Opens Door to New Cancer Treatments
An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Preparing for Potential Zika Outbreaks
Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!